First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.

NCT07377253 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

The Tick-borne Encephalitis Virus (TBEV)

Interventions

DRUG: Human monoclonal antibody TBE025, intravenous infusion

Sponsor

Giuseppe Pantaleo

Collaborators

[object Object]